Numen Alternatives & Competitors
12 companies similar to Numen — Engineering a future without cancer deaths.
Companies similar to Numen
Exai Bio
Delivering next-generation liquid biopsy platform for the earliest detection and most accu...
Palo Alto, United States
Nucleix Ltd.
Developing cancer diagnostic panels based on epigenetic bio markers
Rehovot, Israel
Exosome Diagnostics, a Bio-Techne brand
ExoDx Prostate is the only exosome-based, non-DRE, simple urine test to assess risk for HG...
Waltham, United States
Beacon Biomedical
Easy, Accurate & Affordable Blood Based Screening for early detection of cancer and COVID-...
Phoenix, United States
Track all Numen competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Craif Inc.
Harnessing the power of urinary miRNA to detect cancer early
Irvine, United States
Cleveland Diagnostics
Cleveland Diagnostics is a cancer biotechnology company that is changing the shape of canc...
Cleveland, United States
Hera Biotech
Advancing the Standard of Care in Women's Health Diagnostics
San Antonio, United State...
Travera
Revolutionizing Cancer Therapy Guidance.
Medford, United States
Sherlock Biosciences
Improving health worldwide through accurate, fast and affordable diagnostic testing
Boston, United States
MagBioSense
Pioneering simple, one-step point-of-care diagnostics with laboratory-quality accuracy for...
PreCyte Inc
Envisioning a world free from cancer and neurodegenerative disease
Seattle, United States
Micromedic Technologies Ltd.
Micromedic Technologies specializes in the development and commercialization of innovative...
Israel
About Numen
Numen specializes in developing advanced health care solutions with a focus on synthetic biology and cancer screening. Based in San Francisco, United States, the company caters to healthcare providers, cancer patients, research institutions, and healthcare data analysts. Founded in 2021, Numen provides services such as...
Rapid at-home diagnostics, Health data collection, Proprietary predictive models
Healthcare providers, Cancer patients, Research institutions, Healthcare data analysts
Synthetic Biology, Cancer Screening, At-Home Diagnostics, Lab-Grade Testing, Cancer Biomarkers, Urine Analysis, Rapid Diagnostics, Prostate Cancer Detection, Bladder Cancer Detection, Ovarian Cancer Detection, Biomarker Tracking, Platform Technology, Healthtech Innovation, Personalized Medicine
B2C, D2C, B2B
Product Sales, Service Fee, Subscription
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches Numen and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at Numen on 7 Apr 2026. The 12 companies listed here were last checked between 12 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
